NASDAQ:ATRA
Atara Biotherapeutics Stock News
$0.715
-0.0039 (-0.543%)
At Close: Apr 24, 2024
Atara Biotherapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:01pm, Wednesday, 04'th Jan 2023
THOUSAND OAKS, Calif.--( BUSINESS WIRE )--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to deve
3 Under-the-Radar Biotech Stocks to Buy in 2022
10:07am, Saturday, 24'th Dec 2022
The attraction of all three biotech stocks is their potential.
Consider Atara Biotherapeutics As The Tab-Cel Delay Resolves In The U.S.
08:00am, Saturday, 17'th Dec 2022
Atara Biotherapeutics has complications with the FDA while the EU approach is so much clearer. The MS drug is a value driver if ATRA sorts out issues.
Atara Biotherapeutics, Inc. (ATRA) Q3 2022 Earnings Call Transcript
09:43pm, Tuesday, 08'th Nov 2022
Atara Biotherapeutics, Inc. (NASDAQ:ATRA ) Q3 2022 Results Conference Call November 8, 2022 4:30 PM ET Company Participants Eric Hyllengren - Vice President of Investor Relations and Finance Dr. Pasca
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates
06:48pm, Tuesday, 08'th Nov 2022
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -5.13% and 2.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc
Best Penny Stocks To Buy? 5 Biotech Stocks For Your Watch List This Week
02:13pm, Monday, 24'th Oct 2022
Biotech penny stocks for your watch list this week. The post Best Penny Stocks To Buy?
Stock Market Trends, Penny Stocks in 2022
11:30am, Saturday, 27'th Aug 2022
Are you using these trends to make money with penny stocks? The post Stock Market Trends, Penny Stocks in 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Penny Stocks To Buy Now? 3 To Watch After NERV Stock Explodes 160%
03:53pm, Wednesday, 24'th Aug 2022
Penny stocks to buy or avoid? 3 for your watch list right now.
These Are The Ten Best And Worst Performing Small-Cap Stocks In July 2022
08:08pm, Monday, 22'nd Aug 2022
The small-cap Russell 2000 gained over 10% in July, compared to a jump of 9.1% for the S&P 500.
Atara: 2 Possible Regulatory Approvals For Tab-Cel, Plus CAR T Pipeline
03:19pm, Wednesday, 17'th Aug 2022
Atara has two possible regulatory approvals for tab-cel for PTLD; European approval expected Q4 of 2022 and BLA filing for U.S. territory to be updated in next quarter earnings call. Two data readouts
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Monday, 08'th Aug 2022
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 65.93% and 483.28%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
After Plunging 65.7% in 4 Weeks, Here's Why the Trend Might Reverse for Atara Biotherapeutics (ATRA)
11:21am, Tuesday, 02'nd Aug 2022
Atara Biotherapeutics (ATRA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts
Why Atara Biotherapeutics Stock Is Crashing Today
04:44pm, Wednesday, 13'th Jul 2022
Investors were hoping for more from the company's latest clinical update.
Mizuho On Atara Biotherapeutics - Distinguish Between Small Numbers And Science Failure
01:42pm, Wednesday, 13'th Jul 2022
Atara Biotherapeutics Inc (NASDAQ: ATRA) issued its anticipated interim analysis communication for its ATA188 Phase 2 progressive multiple sclerosis trial. Shares slumped over 50%.
Atara Biotherapeutics (ATRA) Moves 17% Higher: Will This Strength Last?
10:45am, Wednesday, 13'th Jul 2022
Atara Biotherapeutics (ATRA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strengt
